Matches in Wikidata for { <http://www.wikidata.org/entity/Q64172550> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q64172550 description "clinical trial" @default.
- Q64172550 description "ensayu clínicu" @default.
- Q64172550 description "klinisch onderzoek" @default.
- Q64172550 description "клінічне випробування" @default.
- Q64172550 name "Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB and IIIA Non-small Cell Lung Cancer" @default.
- Q64172550 type Item @default.
- Q64172550 label "Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB and IIIA Non-small Cell Lung Cancer" @default.
- Q64172550 prefLabel "Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB and IIIA Non-small Cell Lung Cancer" @default.
- Q64172550 P1132 Q64172550-5A996228-815C-4482-B8B7-92924885BFD6 @default.
- Q64172550 P1476 Q64172550-DDE5F0FB-E018-4787-86C0-EE8620501F4D @default.
- Q64172550 P17 Q64172550-23D07CAF-3FD5-42BD-8A9F-B8784B5EB359 @default.
- Q64172550 P2899 Q64172550-A643B2C6-604E-4C53-9682-93EA3D291832 @default.
- Q64172550 P3098 Q64172550-C3E8AA2E-45FB-48C6-AB48-DCC9753EC89E @default.
- Q64172550 P31 Q64172550-C51303BC-C8E4-4E47-AF2D-299B83591952 @default.
- Q64172550 P4844 Q64172550-563D5C4A-174B-4370-8D77-432C43A02593 @default.
- Q64172550 P4844 Q64172550-E63EC45E-AA68-4908-8ECF-FF8540ED597A @default.
- Q64172550 P580 Q64172550-63790ED1-10FF-488D-BCE1-4FD5E0142AC5 @default.
- Q64172550 P582 Q64172550-B9A3D4D6-079F-4394-AC27-F4B81DB62409 @default.
- Q64172550 P6099 Q64172550-D2370819-8EDF-4B8F-85B0-33488F1B607A @default.
- Q64172550 P6153 Q64172550-EF0A6188-FE62-4578-8FFF-27AB5A387D2A @default.
- Q64172550 P8363 Q64172550-405D22B7-C3A2-45E8-A36A-AB5F73885C16 @default.
- Q64172550 P1132 "+27" @default.
- Q64172550 P1476 "A Single-Arm Phase II Study With a Safety lead-in of Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB and IIIA Non-small Cell Lung Cancer" @default.
- Q64172550 P17 Q30 @default.
- Q64172550 P2899 "+18" @default.
- Q64172550 P3098 "NCT03916419" @default.
- Q64172550 P31 Q30612 @default.
- Q64172550 P4844 Q415588 @default.
- Q64172550 P4844 Q423762 @default.
- Q64172550 P580 "2019-06-30T00:00:00Z" @default.
- Q64172550 P582 "2024-12-31T00:00:00Z" @default.
- Q64172550 P6099 Q42824440 @default.
- Q64172550 P6153 Q7972509 @default.
- Q64172550 P8363 Q78089383 @default.